SKIL and colorectal carcinoma: Our findings revealed a new mechanism of SKIL expression regulation through m5C modification, which suggests that the regulatory mechanism of SKIL expression is epigenetically mediated and that the inhibition of m5C modification in SKIL may have therapeutic benefits for CRC patients.